Chronic Obstructive Pulmonary Disease

Chronic obstructive pulmonary disease (COPD) is a long-term lung condition in which the airways become inflamed and narrowed, making it progressively harder to breathe. It covers two overlapping patterns: emphysema, where the air sacs lose their elasticity, and chronic bronchitis, where the airway lining produces excess mucus. COPD does not reverse, but it can be stabilised and its daily impact significantly reduced.

Medicines used to treat Chronic Obstructive Pulmonary Disease

Symbicort

Budesonide, Formoterol

160/4.5mcg

Designed to manage asthma and chronic obstructive pulmonary disease, intended to alleviate airway inflammation and support breathing function in patients.

From $46.75 / inhaler View

Advair Diskus

Salmeterol, Fluticasone

100/50 · 250/50 · 500/50mcg

This inhaler is developed to target chronic obstructive pulmonary disease and is indicated to alleviate airway inflammation.

From $106.55 / inhaler View

Pulmicort

Budesonide

100 · 200mcg

Intended to mitigate airway inflammation, formulated to support respiratory function and help manage symptoms of chronic asthma or lung conditions.

From $45.05 / inhaler View

Combivent

Ipratropium, Salbutamol

50/20mcg

Formulated to target airway constriction and indicated to support effective breathing in respiratory conditions.

From $22.10 / inhaler View

Spiriva

Tiotropium

9mcg

This inhaler is indicated to relieve chronic obstructive pulmonary disease and is developed to support improved respiratory function.

From $38.25 / inhaler View

Tiova Rotacap

Tiotropium

15caps

Developed to alleviate chronic obstructive pulmonary disease to support better airway function and facilitate ease of breathing.

From $106.00 / bottle View

Proair Inhaler

Salbutamol

100mcg

Indicated to relieve wheezing and formulated to target bronchospasm in asthma and respiratory conditions.

From $15.30 / inhaler View

Tiova Inhaler

Tiotropium

9mcg

Indicated for chronic obstructive pulmonary disease, formulated to alleviate breathing difficulties and support respiratory function in patients managing long-term lung health.

From $38.25 / inhaler View

Budecort

Budesonide

100mcg

Developed for asthma indicated to alleviate airway inflammation.

From $35.02 / inhaler View

Theo-24 Cr

Theophylline

400mg

Formulated to mitigate respiratory restriction and indicated to support ease of breathing.

From $0.60 / tablet View

Uniphyl Cr

Theophylline

400mg

Formulated to support airway patency by relaxing bronchial smooth muscle cells.

From $0.57 / tablet View

Theo-24 Sr

Theophylline

200mg

Designed to target constricted airways, promoting improved airflow and reducing breathing difficulty.

From $1.33 / tablet View

Proventil

Salbutamol

100mcg

Developed to alleviate symptoms of asthma and utilized to support respiratory function by dilating airways during exacerbations.

From $23.09 / inhaler View

Daliresp

Roflumilast

500mg

Product intended to target chronic obstructive pulmonary disease and formulated to alleviate respiratory inflammation.

From $1.04 / tablet View

What drives COPD in Asia

Tobacco smoking is the dominant cause globally, but across South and Southeast Asia, prolonged exposure to biomass cooking smoke, from wood, coal, and crop residue burned indoors, is a major independent risk factor, particularly among women in rural India, Indonesia, and the Philippines. Air quality in dense urban centres such as Bangkok, Jakarta, and Ho Chi Minh City adds further burden. Occupational dust and fume exposure in manufacturing and construction also contribute.

Recognising the pattern of symptoms

COPD typically builds slowly over years. A morning cough producing clear or yellowish mucus, gradually worsening breathlessness on exertion, and a sensation of chest tightness are the hallmark features. Wheezing is common. Many people dismiss early symptoms as a “smoker’s cough” or normal ageing, which delays diagnosis by a decade or more. Acute flare-ups, called exacerbations, produce a sudden worsening of breathlessness, increased mucus, and sometimes fever; these need prompt attention as they accelerate lung decline.

How COPD is managed

Treatment aims to open the airways, reduce inflammation, and prevent exacerbations. Short-acting bronchodilators such as salbutamol relieve breathlessness quickly during a flare. Long-acting bronchodilators like salmeterol and tiotropium provide sustained airway opening throughout the day. Inhaled corticosteroids, budesonide and fluticasone, reduce airway inflammation and are often combined with a long-acting bronchodilator in a single inhaler. Theophylline tablets remain widely used across Asia where inhaler access or cost is a barrier. Pulmonary rehabilitation, structured exercise and breathing training, improves function and quality of life beyond what medicines alone can achieve. Stopping smoking at any stage slows progression.

Seek urgent care if breathlessness becomes severe at rest, lips or fingertips turn bluish, or a flare does not improve within a day or two of starting usual treatment. Browse the full respiratory health range for available options.